<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Exicure, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Exicure, Inc.

    Exicure, Inc. is a clinical stage biotechnology company developing a new class of immunomodulatory and gene regulating drugs against validated targets. Exicure's proprietary 3-dimensional, spherical nucleic acid (SNA™) architecture unlocks the potential of therapeutic oligonucleotides in a wide range of cells and tissues. Exicure's lead programs address oncology, inflammatory diseases and genetic disorders. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      David A. Giljohann
    • FOUNDED
      2009
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Tivity Health, Inc.

    Tivity Health, Inc.

    Tivity Health, IncÂŽ is a leading provider of fitness and health improvement progr...

    Tivity Health, IncÂŽ is a leading provider of f...

    Filing Type:    PU
    Life Imaging Fla, Inc.

    Life Imaging Fla, Inc.

    Our mission is to educate and provide an affordable early detection system for the...

    Our mission is to educate and provide an afford...

    Amount Raised:    $32,726.00
    Fundraising Status:    EC
    Filing Type:    CF
    Gulf Chronic Care Inc

    Gulf Chronic Care Inc

    Gulf Chronic Care, Inc. was established specifically to address the diabetic epide...

    Gulf Chronic Care, Inc. was established specifi...

    Filing Type:    RA
    CytoDyn Inc.

    CytoDyn Inc.

    CytoDyn is a publicly traded late stage biotechnology company developing innovativ...

    CytoDyn is a publicly traded late stage biotech...

    Filing Type:    PU
    Biofrontera AG

    Biofrontera AG

    We have specialized in dermatology, as your skin's health is our concern. We aim t...

    We have specialized in dermatology, as your ski...

    Filing Type:    PU
    Kamada Ltd.

    Kamada Ltd.

    Kamada Ltd. is focused on plasma-derived protein therapeutics for orphan indicatio...

    Kamada Ltd. is focused on plasma-derived protei...

    Filing Type:    PU
    Celyad SA

    Celyad SA

    Celyad is a biopharmaceutical company, specialized in CAR-T cell therapy, that is ...

    Celyad is a biopharmaceutical company, speciali...

    Filing Type:    PU
    Nymox Pharmaceutical Corporation

    Nymox Pharmaceutical Corporation

    Nymox Pharmaceutical Corporation specializes in the research and development of th...

    Nymox Pharmaceutical Corporation specializes in...

    Filing Type:    PU
    Synthorx, Inc.

    Synthorx, Inc.

    Synthorx is a biotechnology company focused on prolonging and improving the lives ...

    Synthorx is a biotechnology company focused on ...

    Filing Type:    PU
    Gossamer Bio, Inc.

    Gossamer Bio, Inc.

    Gossamer Bio is a clinical-stage biopharmaceutical company focused on discovering,...

    Gossamer Bio is a clinical-stage biopharmaceuti...

    Filing Type:    PU
    Viela Bio, Inc.

    Viela Bio, Inc.

    Viela is dedicated to the development and commercialization of novel, life-changin...

    Viela is dedicated to the development and comme...

    Filing Type:    PU
    ChemoCentryx, Inc.

    ChemoCentryx, Inc.

    ChemoCentryx is a biopharmaceutical company focused exclusively on discovering, de...

    ChemoCentryx is a biopharmaceutical company foc...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.